Fig. 3
From: One of the 5-aminosalicylates drug, mesalamine as a drug repurposing lead against breast cancer
Dose-dependent inhibition and morphological alterations of MCF-7 cells treated with different concentrations of mesalamine. A shows the nonlinear regression curve for MCF-7 cells treated with different concentrations of mesalamine incubated for 24 h. B Control well with no treatment C–G shows the cells treated with 5 µM, 20 µM, 50 µM and 100 µM concentrations of mesalamine respectively. Scale Bar 100 µM